Cargando…
Correction to: Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732224/ https://www.ncbi.nlm.nih.gov/pubmed/35932280 http://dx.doi.org/10.1093/oncolo/oyac166 |
_version_ | 1784846079156551680 |
---|---|
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-9732224 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-97322242022-12-13 Correction to: Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab Oncologist Correction Notices Oxford University Press 2022-08-06 /pmc/articles/PMC9732224/ /pubmed/35932280 http://dx.doi.org/10.1093/oncolo/oyac166 Text en © The Author(s) 2022. Published by Oxford University Press. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Correction Notices Correction to: Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab |
title | Correction to: Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab |
title_full | Correction to: Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab |
title_fullStr | Correction to: Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab |
title_full_unstemmed | Correction to: Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab |
title_short | Correction to: Multicenter Real-World Study on Effectiveness and Early Discontinuation Predictors in Patients With Non-small Cell Lung Cancer Receiving Nivolumab |
title_sort | correction to: multicenter real-world study on effectiveness and early discontinuation predictors in patients with non-small cell lung cancer receiving nivolumab |
topic | Correction Notices |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9732224/ https://www.ncbi.nlm.nih.gov/pubmed/35932280 http://dx.doi.org/10.1093/oncolo/oyac166 |